B
Barclays Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
951
Amneal Pharmaceuticals
AMRX
$3.06B
|
BP
Balaji Prasad
| $9.89 | $11 |
11%
upside
| Overweight |
3 Mar ‘25
6 months ago |
|
952
Pacira BioSciences
PCRX
$1.2B
|
BP
Balaji Prasad
| $26.30 | $24 |
9%
downside
| Overweight |
28 Feb ‘25
6 months ago |
|
953
Viatris
VTRS
$12.2B
|
BP
Balaji Prasad
| $10.45 | $9 |
14%
downside
| Underweight |
28 Feb ‘25
6 months ago |
|
954
JD.com
JD
$48B
|
GZ
Gregory Zhao
| $33.87 | $55 |
62%
upside
| Overweight |
28 Feb ‘25
6 months ago |
|
955
Excelerate Energy
EE
$736M
|
MS
Marc Solecitto
| $23.02 | $32 |
39%
upside
| Overweight |
28 Feb ‘25
6 months ago |
|
956
Vir Biotechnology
VIR
$721M
|
GW
Gena Wang
| $5.24 | $31 |
492%
upside
| Overweight |
28 Feb ‘25
6 months ago |
|
957
Intellia Therapeutics
NTLA
$1.28B
|
GW
Gena Wang
| $11.88 | $26 |
119%
upside
| Overweight |
28 Feb ‘25
6 months ago |
|
958
Ituran Location and Control
ITRN
$685M
|
TR
Tavy Rosner
| $34.59 | $50 |
45%
upside
| Overweight |
27 Feb ‘25
6 months ago |
|
959
Fluor
FLR
$6.6B
|
AS
Adam Seiden
| $40.71 | $40 |
2%
downside
| Equal-Weight |
27 Feb ‘25
6 months ago |
|
960
Jazz Pharmaceuticals
JAZZ
$7.88B
|
BP
Balaji Prasad
| $128.53 | $200 |
56%
upside
| Overweight |
27 Feb ‘25
6 months ago |
|
961
Zeta Global
ZETA
$4.45B
|
RM
Ryan Macwilliams
| $18.70 | $18 |
4%
downside
| Equal-Weight |
27 Feb ‘25
6 months ago |
|
962
Geron
GERN
$868M
|
PL
Peter Lawson
| $1.36 | $4 |
194%
upside
| Overweight |
27 Feb ‘25
6 months ago |
|
963
Zoom
ZM
$25.6B
|
RM
Ryan Macwilliams
| $85.62 | $80 |
7%
downside
| Equal-Weight |
26 Feb ‘25
6 months ago |
|
964
Elanco Animal Health
ELAN
$9.46B
|
BP
Balaji Prasad
| $18.76 | $19 |
1%
upside
| Overweight |
26 Feb ‘25
6 months ago |
|
965
Viasat
VSAT
$4.04B
|
MR
Mathieu Robilliard
| $30.87 | $10 |
68%
downside
| Equal-Weight |
26 Feb ‘25
6 months ago |
|
966
Tarsus Pharmaceuticals
TARS
$2.4B
|
BP
Balaji Prasad
| $56.49 | $60 |
6%
upside
| Overweight |
26 Feb ‘25
6 months ago |
|
967
Revolve Group
RVLV
$1.67B
|
TY
Trevor Young
| $23.56 | $26 |
10%
upside
| Equal-Weight |
26 Feb ‘25
6 months ago |
|
968
Exelon
EXC
$43.4B
|
NC
Nicholas Campanella
| $43.09 | $48 |
11%
upside
| Overweight |
25 Feb ‘25
6 months ago |
|
969
Liberty Latin America Class A
LILA
$1.57B
|
MR
Mathieu Robilliard
| $7.73 | $6.50 |
16%
downside
| Underweight |
25 Feb ‘25
6 months ago |
|
970
Globus Medical
GMED
$8.04B
|
MM
Matt Miksic
| $59.08 | $103 |
74%
upside
| Overweight |
24 Feb ‘25
6 months ago |
|
971
Nice
NICE
$8.83B
|
TR
Tavy Rosner
| $143.35 | $226 |
58%
upside
| Overweight |
21 Feb ‘25
6 months ago |
|
972
FIVE9
FIVN
$2.06B
|
RM
Ryan Macwilliams
| $26.38 | $60 |
127%
upside
| Overweight |
21 Feb ‘25
6 months ago |
|
973
RingCentral
RNG
$2.94B
|
RM
Ryan Macwilliams
| $31.76 | $31 |
2%
downside
| Equal-Weight |
21 Feb ‘25
6 months ago |
|
974
Bandwidth Inc
BAND
$473M
|
RM
Ryan Macwilliams
| $15.59 | $22 |
41%
upside
| Overweight |
21 Feb ‘25
6 months ago |
|
975
Grab
GRAB
$21.6B
|
JS
Jiong Shao
| $5.29 | $6.50 |
23%
upside
| Overweight |
20 Feb ‘25
6 months ago |
|